![Viracta Therapeutics Inc](/common/images/company/N_VIRX.png)
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more
SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1101 | 23.4305171313 | 0.4699 | 0.555 | 0.452 | 147338 | 0.49855396 | CS |
4 | -0.1 | -14.7058823529 | 0.68 | 0.694 | 0.45 | 111409 | 0.53474488 | CS |
12 | -0.27 | -31.7647058824 | 0.85 | 0.91 | 0.45 | 89068 | 0.62884297 | CS |
26 | -0.0402 | -6.48178007094 | 0.6202 | 1.31 | 0.45 | 102294 | 0.75923743 | CS |
52 | -0.88 | -60.2739726027 | 1.46 | 1.68 | 0.43 | 115147 | 0.77839698 | CS |
156 | -10.13 | -94.5845004669 | 10.71 | 11.65 | 0.43 | 165710 | 2.9603009 | CS |
260 | -16.18 | -96.5393794749 | 16.76 | 18.24 | 0.43 | 192066 | 4.74824541 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.